Trial Profile
A Study to Compare the Efficacy and Safety of Solifenacin, Mirabegron and their Combination in Elderly Patients With Overactive Bladder (OAB)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Mar 2016
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary) ; Solifenacin (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 07 Mar 2016 New trial record